According to the 2020 Global Cancer Epidemiology Statistics (GLOBOCAN) report, breast cancer has surpassed lung cancer to become the most prevalent form of cancer, with an estimated 2.3 million new cases recorded in 2020, accounting for a staggering 11.7% of all new cancer diagnoses worldwide. It...
HER2-positive breast cancer historically had the highest rates of recurrence but has substantially improved outcomes with the advent of targeted anti-HER2 therapies. NRG-BR008/HERO is a Phase III randomized trial evaluating whether adjuvant radiotherapy remains beneficial in low-risk HER2-positive breast...
Breast cancer is the most common cancer diagnosed in women worldwide, with 2.2 million newly diagnosed cases in 2022 alone [1]. Prognosis from breast cancer improved remarkably in high-income settings over recent decades. In Sweden, 5-year age-standardised relative survival from breast cancer increased...
In 2020, breast cancer in women surpassed lung cancer as the leading contributor to the global incidence of cancer; an estimated 2.3 million new cases were reported, representing 11.7% of all cancer cases [1]. During the past 2 decades, the survival of patients with breast cancer has notably improved....